Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China
· Delayed Price · Currency is CNY 51.28
-1.53 (-2.90%)
At close: Mar 9, 2026
Shanghai Rendu Biotechnology Company Description
Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of RNA molecular diagnostic technology and products.
It offers products in the areas of reproductive health, bloodborne infections, respiratory infections, enterovirus infections, cancer early detection, and other areas; and AutoSAT, SuperSAT, and ultrasonic homogenizer.
The company was founded in 2007 and is based in Shanghai, China.
Shanghai Rendu Biotechnology Co., Ltd.
| Country | China |
| Founded | 2007 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 290 |
| CEO | Minghui Yu |
Contact Details
Address: Zhangjiang High Tech Park Shanghai, 201201 China | |
| Phone | 86 21 5072 0200 |
| Website | rdbio.com |
Stock Details
| Ticker Symbol | 688193 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000059K5 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Minghui Yu | GM and Director |
| Tingjiang Cai | Accounting Supervisor, Chief Financial Officer and Secretary |
| Ruohua Cao | Deputy GM and Director |
| Zhenling Cui | Senior Director of Research & Development |
| Ho Kim | Deputy Director of Instrumentation |
| Feng man Zhou | Deputy Director of Instrumentation |
| Chang E Zhang | Registration Director |